Volume 3, Issue 12, September 19, 2013
This Week's Top Stories
1. As Opioid Use Soars, No Evidence of Improved Treatment of Pain
2. Alternatives to Long-Term Opioid Use for Chronic Pain
3. Bills Would Give State New Powers to Fight Rx Drug Abuse
4. Six in Ten Drug Ads on TV Contain False Claims by Drug Manufacturers
Summit Spotlight:

The National Rx Drug Abuse Summit is now accepting presentation proposals to be included as a speaker at the 2014 Summit. Presentations should stimulate critical thinking  and provide innovative, cutting edge solutions for the Rx drug abuse epidemic. The deadline to submit a presentation is Monday, September 30. For more information on how to submit an abstract, click here.

This Week's Top Stories

A new study led by the Johns Hopkins Bloomberg School of Public Health finds that during a decade when prescription opioid use has skyrocketed, the identification and treatment of pain has failed to improve, and the use of non-opioid analgesics has plateaued, or even declined. The study was published online September 13 in the journal Medical Care.


"There is an epidemic of prescription opioid addiction and abuse in the United States," notes G. Caleb Alexander, MD, MS, associate professor of Epidemology and Medicine and co-director of the Johns Hopkins Center for Drug Safety and Effectiveness. "We felt it was important to examine whether or not this epidemic has coincided with improved identification and treatment of pain."


  To read more, click here.

In the second of a two-part series, Join Together speaks with Barry Meier, New York Times reporter and author of the new e-book, "A World of Hurt: Fixing Pain Medicine's Biggest Mistake," about the alternatives to long-term opioid use for treating pain.


Is there a movement back toward a multidisciplinary approach to treating chronic pain? What could the advantages of this approach be?


Barry Meier: One of the reasons that I wrote A World of Hurt was to try to help stimulate a public discussion about alternatives to opioids. It was not to bash these drugs because they do play a valuable role. But the experience of the past decade has proven two things: The first is that opioids are not the cure-all that drug companies and their advocates claimed. The second thing is that patients, the public and doctors need to expand the conversation about pain treatment beyond how the drug industry has sought to define it.


To read more of the interview, click here.

Since her son Joey fatally overdosed in late 2009, April Rovero has warned schoolchildren, coeds, cops and congressmen that it was too easy for the 21-year-old college student to get the Rx drugs that killed him.


In speeches from Sacramento to Washington, she complained bitterly that authorities had suspected a Rowland Heights doctor of reckless prescribing for years but did little to stop her. Rovero's son was one of at least eight men who died on drugs the doctor prescribed.


Rovero's frustration mounted over the years as she saw other families lose loved ones to a growing prescription drug epidemic. But now, she sees reason for hope.


Last week, state lawmakers passed an ambitious slate of reforms aimed at giving authorities better tools and broader powers to crack down on doctors who recklessly prescribe narcotic painkillers and other commonly abused drugs.


To read more, click here.


Researchers have warned consumers that they should be wary of advertisements for pharmaceuticals on the nightly TV news, as six out of 10 claims could potentially mislead the viewer.


Researchers Adrienne E. Faerber of The Dartmouth Institute for Health Policy and Clinical Practice and David H. Kreling of The University of Wisconsin-Madison School of Pharmacy found that potentially misleading claims are prevalent throughout consumer-targeted prescription and non-prescription drug advertisements on television.


"Healthcare consumers need unrestricted access to high-quality information about health, but these TV drug ads had misleading statements that omitted or exaggerated information," said Faerber.


To read more, click here.


More than 30 people in El Paso County face state charges in connection with a multiagency law enforcement operation targeting prescription drug abuse. The arrests were part of an investigation involving federal, state and local agencies.


During a news conference Wednesday morning, officials announced the arrests of 33 people on prescription fraud-related offenses. Some of the suspects are also charged with engaging in organized criminal activity.


Officials said more than 300 prescriptions and 32,000 pills were involved in the investigation, which began in June 2011, said Joseph Arabit, the special agent in charge of the Drug Enforcement Administration in El Paso.


To read more, click here.


Register Now...

Big savings!

$395 ~ Clinical, Gov't
and Non-profit Rate
$795 ~ Corporate Rate
Tuesday, April 22 -
Thursday, April 24, 2014
265 Peachtree Center Ave NE
Atlanta, GA 30303
The National Rx Drug Abuse Summit is the largest national collaboration for individuals impacted by Rx Drug Abuse.
To view presentations from the 2013 Rx Drug Abuse Summit, click here.
On the Website

Stay Connected

Like us on Facebook    Follow us on Twitter    View our profile on LinkedIn